Adjunctive diagnostic utility of POU2F3 in predominantly pulmonary high-grade neuroendocrine carcinomas with limited or discordant conventional marker expression: a case-control study.

Hu X, Wang X, Li C.

Open source

DOI
10.3389/fmed.2026.1886172
Published
2026-09-08
Container
Front Med (Lausanne)
Publisher
Not recorded
Open access
no

Credibility signals

uncertain Score 51/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fmed.2026.1886172,
  title = {Adjunctive diagnostic utility of POU2F3 in predominantly pulmonary high-grade neuroendocrine carcinomas with limited or discordant conventional marker expression: a case-control study.},
  author = {Hu X and  Wang X and  Li C.},
  year = {2026},
  journal = {Front Med (Lausanne)},
  doi = {10.3389/fmed.2026.1886172},
  url = {https://doi.org/10.3389/fmed.2026.1886172}
}

RIS

TY  - JOUR
TI  - Adjunctive diagnostic utility of POU2F3 in predominantly pulmonary high-grade neuroendocrine carcinomas with limited or discordant conventional marker expression: a case-control study.
AU  - Hu X
AU  -  Wang X
AU  -  Li C.
PY  - 2026
JO  - Front Med (Lausanne)
DO  - 10.3389/fmed.2026.1886172
UR  - https://doi.org/10.3389/fmed.2026.1886172
ER  - 

APA

X, H., X, W., & C., L. (2026). Adjunctive diagnostic utility of POU2F3 in predominantly pulmonary high-grade neuroendocrine carcinomas with limited or discordant conventional marker expression: a case-control study.. Front Med (Lausanne). https://doi.org/10.3389/fmed.2026.1886172

Source records